Overweight and obesity are associated with a low sperm quality

July 27, 2020

Infertility affects between 10 and 15% of all couples of reproductive ages and can be caused by a wide variety of factors: genetic, physiological, environmental and nutritional.Although there is increasing scientific evidence about the role of nutrition in sperm quality, there is still controversy about the role of overweight, obesity and low weight in sperm parameters.

Researchers from the Human Nutrition Unit of the Rovira i Virgili University and the CIBERobn in collaboration with researchers from the University of Utah (USA), researchers from the Ahvaz Jundishapur University and the National University of Córdoba (Argentina),have carried out a systematic review and meta-analysis of all the existing observational scientific literature, evaluating the association between adiposity(normal weight, overweight, obesity, and low weight) and the sperm quality determined by a seminogram.

A total of 60 articles were included in the qualitative analysis and 28 in the quantitative analysis. The researchers indicated that overweight and/or obesity were associated with low semen quality parameters (i.e., semen volume, sperm count and concentration, sperm vitality, total motility and normal morphology) and underweight category was likewise associated with low sperm normal morphology.

According to the researchers, this work provides the most comprehensive analysis to date of the high-quality research and demonstrates the importance of adiposity in semen quality.

Albert Salas-Huetos, first author of the article states that these results "suggest that overweight/obesity prevention should be considered at an early age to avoid deleterious effects on reproductive health". Researchers also point out that additional studies are warranted to elucidate thepotential benefits of weight loss for improving reproductive potential in individuals with obesity.

The results of the present study, conducted by the post-doctoral researcher Dr. Albert Salas-Huetos, currently working at the University of Utah, in collaboration with researchers from the Human Nutrition Unit of the Rovira i Virgili University and the CIBERobn led by Professor Jordi Salas-Salvadó, have been published in the prestigious scientific journal Obesity Reviews. It is one of the most impactful scientific journals in the Endocrinology and Metabolism area.
Reference: Salas-Huetos A, Maghsoumi-Norouzabad L, James ER, Carrell DT, Aston KI, Jenkins TG, Becerra-Tomás N, Javid AZ, Abed R, Torres PJ, Luque EM, Ramírez ND, Martini AC, Salas-Salvadó J. "Male adiposity, spermparameters and reproductive hormones: Anupdatedsystematicreview and collaborative meta-analysis". Obesity Reviews, 2020; https://onlinelibrary.wiley.com/doi/abs/10.1111/obr.13082.

Universitat Rovira i Virgili

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.